AliveCor Stock

alivecor.comHealthcareFounded: 2010Funding to Date: $277.15MM

With a mission to save lives and transform cardiology by delivering intelligent, highly-personalized heart data to clinicians and patients anytime, anywhere, AliveCor, founded in 2010 with headquarters in Mountain View, CA, is transforming cardiological care using deep learning.

Register for Details

For more details on financing and valuation for AliveCor, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for AliveCor.

Register Today

AliveCor investors also invested in these private companies

Team

Management Team

Priya Abani
Chief Executive Officer
David E. Albert, MD
Founder, Chief Medical Officer
Clyde Hosein
Chief Financial Officer
Siva Somayajula
Chief Technology Officer
Alfred Woo
Chief Product Officer
Sanjay Voleti
Chief Strategy Officer
Vincent Balsamo
Executive Vice President, Global Sales
Jessica Weinstein
Senior Vice President, Marketing
Brian Clarke
General Counsel
Archana Dubey, MD
Chief Clinical Officer
Ben Green, MD
Senior Vice President, Services

Board Members

Vinod Khosla
Khosla Ventures
Negel Blakeway
Omron Management Centers of Americas
Toby Cosgrove, M.D.
Cleveland Clinic
Sebastian Thrun
Kitty Hawk Corporation
Ranndy Kellogg
Omron Healthcare
Ryan Phillips
WP Global Partners

Other companies like AliveCor in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM

News

AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced its Series F Financing led by GE Healthcare.